Phase II Pilot Study of Cytarabine for Refractory Systemic Lupus Erythematosus

NCT00004643 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

10

Enrollment

NIH

Sponsor class

Conditions

Lupus Erythematosus, Systemic

Interventions

DRUG: cytarabine

Sponsor

National Center for Research Resources (NCRR)

Collaborators

[object Object]